Ivan  Topisirovic

Assistant Professor

Oncology

CIHR New Investigator Award

Address:
Lady Davis Institute
Jewish General Hospital
Room F635
3755, CĂ´te Ste.Catherine Road
Montreal, QC H3T 1E2

Telephone: 514-340-8222 x 23146
E-mail: ivan.topisirovic@mcgill.ca

Education: Ph.D., M.Sc.; University of Belgrade

Research Focus: Regulation of mRNA Translation; Signal Transduction; Cell Growth and Proliferation; Mammalian Target of Rapamycin (mTOR) Pathway; Prostate Cancer; Breast Cancer


Recent Presentations:

Hulea L.*, Gravel S.P.*, Toban N.*, Birman E., Blouin M.J., Zakikhani M., St-Pierre J., Topisirovic I. and Pollak M. Serine Deprivation enhances anti-tumour effects of biguanides. Signalling in normal and cancer cells. Banff, Alberta, March 23-27, 2014. * These authors contributed equally to this work

Gandin V, McLaughlan S, Larose L, Trost M, Topisirovic I. eIF2β links mTOR and eIF2α signaling. TRANSLATIONAL CONTROL, CSHL, Cold Spring Harbor, NY, USA, September 2-6, 2014.

Recent Publications:

Please click here for Dr. Ivan Topisirovic’s complete publication list.